CURRICULUM VITAEPERSONAL:
Name:

Kai Hong, M.D.

Business Address:
Deparment of Urology; Department of Reproducitve Medcine
No.49, North Garden Road
Haidian District, Beijing, China
Post code: 100191
Cell (Work): +86-15611908071
Cell (Private): +86-13501213023
Email (Work): kenhong99@bjmu.edu.cn
Email (Private): kenhong99@hotmail.com
Languages:

Fluent in English, Chinese

EDUCATION
1992-1997

Five-year medical program
Bachelor in Clinical medicine
Beijing Medical University

1997-2002

M.D. of Urology and Andrology
Peking University, Health Science Center

2002- Present

Attending of Urology and AndrologyPeking University Third Hospital

2012

Visiting Schoolar
Department of Urology, Cleveland Clinic

3/1/24

2012

Visiting Schoolar
Male infertility microsurgery training program
Department of Urology, New York Presbyterian Hospital

HOSPITAL POSITIONS
2022-presentVice director
Department of Urology
Department of Reproductive Medicine
Peking University Third Hospital
LICENSURE
2002

Chinese Medical Licensing Examination
PassedPROFESSIONAL SOCIETIES AND ACADEMIC POSITIONS (PRESENT)
Member of Standing Committee, Andrology branch of Chinese Medical Association
Deputy director, Male reproductive medicine group of reproductive medicine
professional committee of Chinese Medical Association
Deputy director, Surgery group of Andrology branch of Chinese Medical Association
Member, Basic science research group of Urology branch of Chinese MedicalAssociationVice chairman, Andrology branch of Beijing Medical Association
Member of the Standing Committee, Reproductive infection and microbiology branchof China Council for the promotion of medical science
Editorial board member, Chinese Journal of Urology, Chinese Journal of minimallyinvasive surgery, Chinese Journal of Andrology.

RESEARCH GRANTS
Funding Source:
Period:Grant Title:
No:
Funding Source:
Period:Grant Title:
No:
Funding Source:
Period:Grant Title:
No:

3/1/24

National Key Research and Development Program of China
2017.12 – 2021.06
Damage of reproductive system caused by environmental andiatrogenic factors and its protection
2017YFC1002001
National Key Research and Development Program of China
2019.01 – 2021.12
Identification and interaction of environmental and genetic
pathogenic factors in infertility population
2018YFC1004202
Beijing Municipal Natural Science Fundation
2018.01 – 2021.12
Leydig stem cell autograft for treatment of hypogonadism inKlinefelter syndrome and its molecular mechanism
7182177

Funding Source:
Period:Grant Title:

No:

Capital’s Funds for Health Improvement and Research2022.01– 2024.12
Diagnosis and treatment of Improving the reproductive outcome ofazoospermia patients with Y chromosome AZFc microdeletion
after micro-dissection of testicular sperm extraction2022-2-4094

PUBLICATIONS ( THE FIRST AUTHOR OR CORRESPONDENCE AUTHOR)
1. Jian Chen, Chenxu Cao, Mengcheng Luo, et al. MicroRNA-202 safeguards
meiotic progression by preventing premature SEPARASE-mediated REC8cleavage. EMBO reports. 2022, e54298
2. Consensus of diagnosis and treatment of azoospermia by Chinese experts,
Chin J Reprod Contracet, July 2021, 41(7): 573-585
3. Xiaotong Wang, Mengyuan Qu, Zili Li, Yuting Long, Kai Hong and Honggang Li.
Valproic acid promotes the in vitro differentiation of human pluripotent stem cells
into spermatogonial stem cell-like cells， Stem Cell Research & Therapy.
2021:12:553
4. Hong-Liang Zhang, Lian-Ming Zhao, Jia-Ming Mao, et al. Sperm retrieval rates
and clinical outcomes for patients with different causes of azoospermia who
undergo microdissection testicular sperm extraction-intracytoplasmic sperminjection. Asian Journal of Andrology. 2021,23:59-63
5. Fang Nanning，Hong Kai，Ge Huiyu，Hao Yichang，Fang Yangyi，Tian Yu，Sun Yang，Jiang Hui，Ma Lulin .Use of real-time transrectal ultrasoundguidance in seminal vesiculoscopy, Chinese Journal of Urology. 2021,42(1):3842.
6. Wang Shouyang, Hong Kai, Tian Yu, et al. Multifactor analysis of postoperative
patency of microsurgical vasoepididymostomy, Chinese Journal of Urology.
2018,39（6）：441-445.
7. Liu DF, Zhao LM, Hong K, Mao JM, Yang YZ, Zhang Z, Jiang H. Fertilityachieved through in vitro fertilization in a male patient with 48,XXYY syndrome.
Asian J Androl. 2018 Mar-Apr;20(2):208-209.
8. Hong K, Zhao LM, Xu SX, Tang WH, Mao JM, Liu DF, Jiang H, Ma LL, Qiao J.
Multiple factors affecting surgical outcomes and patency rates in use of singlearmed two-suture microsurgical vasoepididymostomy: a single surgeon'sexperience with 81 patients. Asian J Androl. 2016， 18: 129-133
9. Hong Kai ， Zhao Lianming ， Tang Wenhao, et al. Microsurgical Crossed
Vasovasostomy for Complicated Obstructive Azoospermia. Chinese Journal of
Minimally Invasive Surgery. 2015，15（3）：228-231.
10. Hong Kai, et al. Efficacy and safety of 120-W Thulium: Yttrium-Aluminum-Garnet

3/1/24

vapoenucleation of prostates compared with Holmium laser enucleation ofprostate for benign prostatic hyperplasia, Chin Med J (Engl). 2015
Apr;128(7):884-889
11. Hong Kai，Liu Yu-qing，Lu Jian，Xiao Chun-lei，Huang Yi，Ma Lu-lin. Effectand impact of holmium laser versus thulium laser enucleation of the prostate on
erectile function. National Journal of Andrology. 2015,21（3）：245-250.
12. Hong Kai, Liu Defeng ,Jiang Hui, Zhao Lianming, Tang Wenhao, Mao Jiaming,
Zhang Hongliang , Yang Yuzhuo, Zhang Zhe. Factors affecting the quality ofsexual life and quality of sexual life of ED patients after treatment of PDE5
inhibitor》, Chinese Journal of Human Sexuality.2015,(3)：3-6.
13. Hong Kai, Xu qingquan, Zhao Yongping, et al. Andrology in China: current
status and 10 years’ progress. Asian J Androl. 2011 Jul;13(4):512-518.
PARTICIPATED PUBLISHED BOOKS ( PARTIAL)
1. Chinese guideline of diagnosis and treatment on urology and andrology, 2019edition, (2020 )2.

Wu Jieping Urology, 2nd edition, (2019 )3.

Chinese experts consensus of diagnosis and treatment on andrology. (2017)

4. Clinical guideline of reproductive medicine. (2014)
5. Minimally invasive surgery in reproductive medicine. ( 2012)6.

Guideline of LOH diagnosis and treatment. (2009)

Patent (in the last 5 years)
1. Yangyi Fang, Kai Hong, Wei He. A kind of holder for vasovasostomy. No: ZL 2020 23247870.9（Patent for Utility Models & Authorized）
2. Yu Tian, Kai Hong. A pull hook for microsurgical varicocele repair. No: ZL 2019 20883117.7（Patent for Utility Models & Authorized）
Major WrokDr. Hong is focused on clinical and research of male infertility, especially onazoospermia.
Dr. Hong is one of the best surgeon on male infertility microsurgery in China. He pioneered andcompleted the first micro-dissection testicular sperm extraction (mTESE), the first micro-surgicalvasoepididymostomy, the first micro-surgical vasovasostomy and vesical seminal scopy in hishospital ( Peking University Third Hospital, rank top one in reproductive medicine in China in the
3/1/24

last five years) in 2009. Dr. Hong’s surgical experience of mTESE, microsurgicalvasoepididymostomy are totally more than 3000 cases. He is one of the most experienced surgeon
on mTESE and VE surgery in China. Invited lectures and scientific presentations by Dr. Hongwere dozens of times each year all over the country. It has carried out surgical demonstration,
surgical guidance and difficult case consultation in dozens of large-scale comprehensive hospitalurology or reproductive medicine centers in China each year.

3/1/24